JPRN-UMIN000008041已完成未知
Evaluation of combinational effect of Aprepitant on nausea and vomiting induced by chemotherapy (moderate risk) in patients with Gastric Cancer or Colorectal Cancer - Emend
Osaka Medical College Hospital0 个研究点目标入组 100 人开始时间: 2012年5月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patient who has severe liver failure or renal failure (2) Patient who has vomited or provoked nausea in the 24 hours prior to start of chemotherapy (3) Patient who has a factor that induces nausea or vomitting except chemotherapy (brain tumor, obstruction of gastrointestinal tract, active peptic ulcer, brain metastasis et al) (4) Patient who is considered inappropriate as a target patient by a physician-in-charge
研究者
相似试验
已完成
不适用
Evaluation of combinational effect of Aprepitant and Dxamethasone on nausea and vomiting induced by high-emetic-risk chemotherapy in patients.JPRN-UMIN000010818Osaka Medical College Hospital200
尚未招募
3 期
A study to assess the competency of drugs between ondansetron and aprepitant in preventing patient with post surgical nausea and vomiting.CTRI/2023/07/055093Dr. Sathya priya
尚未招募
不适用
Aprepitant as a premedication for prevention of post operative nausea and vomiting (PONV).CTRI/2021/11/037883JSS MEDICAL COLLEGE AND HOSPITA
招募中
3 期
Evaluation of the efficacy of Aprepitant in vomiting of children with cancerMalignant cancer.Agranulocytosis secondary to cancer chemotherapyD70.1IRCT20200204046377N1Shahid Beheshti University of Medical Sciences30
已完成
不适用
The effect of oral Aprepitant and Ondansetron injection on postoperative nausea and vomitingIRCT2016120831302N1Vice President of Research, Kurdistan University of Medical Sciences90